Graham has moved into a more durable growth phase, powered by record backlog, defense-heavy demand, and improving margins. But the stock already prices in much of that progress, leaving a Hold case despite strong operating momentum.
Graham Corporation (GHM) is a niche industrial compounder that has moved out of turnaround territory and into a more durable growth phase, but the stock already reflects a large part of that improvement. The core bull case rests on hard numbers: FY2026 revenue rose 17% to $245.3M, backlog reached a record $532.6M, full-year orders hit $359M, and book-to-bill was 1.5x. That kind of backlog expansion is not cosmetic. It gives Graham unusually strong medium-term visibility for a company with a market cap near $1.19B.
The business quality has also improved. Annual revenue climbed from $97.5M in FY2021 to $209.9M in FY2025 and then to $245.3M in FY2026, while net income improved from a $8.8M loss in FY2022 to $12.2M in FY2025 and full-year FY2026 GAAP EPS of $1.12. Gross margin reached 25.2% in FY2025, and management guided FY2027 gross margin to 24.5% to 25.5% with adjusted EBITDA of $35M to $40M. That points to a business with better scale, better mix, and better operating discipline than it had a few years ago.
The catch is valuation. GHM trades at 79.3x trailing earnings, 54.9x forward earnings, and 3.05x PEG based on the provided data. Analyst consensus is split between 1 Buy and 1 Hold, with a target of $100.25, while a separate six-analyst target set sits at $81.67 against a June 5, 2026 share price of $106.81. Even allowing for backlog strength, defense exposure, and the FlackTek acquisition, that is a demanding setup for a moderate-risk investor. The stock still looks like a good business, but not an easy price.
For a balanced investor with a medium-term horizon, the right stance is constructive but selective. Graham has real momentum, real niche advantages, and real balance-sheet flexibility. It also has heavy defense concentration, project timing risk, and a valuation that leaves less room for mistakes. That combination supports a Hold rating with upside only if execution on backlog conversion, FlackTek integration, and FY2027 margin expansion continues at the current pace.
Get AI-powered research reports, daily market intelligence, and a personal analyst in your pocket.
Get Full Access →The business model is built around highly engineered, mission-critical equipment rather than commodity hardware. That matters because customers buying propulsion systems, vacuum systems, condensers, cryogenic pumps, or thermal management systems do not shop the way they buy steel pipe. They care about qualification, reliability, and performance under harsh conditions. Graham’s 10-K states that it has built a leading position, and in some cases a sole-source position, in certain defense systems and equipment.
Revenue recognition also shows the nature of the model. In fiscal 2026, about 82% of revenue was recognized over time, while about 18% was recognized upon shipment. That means Graham is not simply selling off-the-shelf units. It is executing long-cycle contracts where labor hours, cost-to-complete, and operational milestones drive reported revenue. The upside is visibility when backlog is high. The downside is that quarterly results can be lumpy and sensitive to milestone timing.
The company has become far more defense-heavy over time. Segment data shows FY2026 revenue of $161.95M split between Defense at $147.45M, or 91.0%, and Space at $14.51M, or 9.0%. That compares with FY2024, when Defense was 60.4% of segment revenue, Refining was 17.7%, Other Commercial was 13.8%, and Space was 8.1%. The mix shift has improved visibility and likely improved margin quality, but it has also concentrated the business around defense budgets and program execution.
Defense is now the engine room of Graham’s growth. In the fiscal third quarter of 2026, management said defense sales increased by $8.3M, driven by project milestones, new programs, better pricing, and growth across existing programs. The company also said roughly 85% of backlog was attributable to defense. That is a powerful fact because backlog reached $515.6M at the end of Q3 FY2026 and then $532.6M at FY2026 year-end. A defense-heavy backlog of that size gives Graham a long runway for revenue conversion.
The company’s defense exposure is tied heavily to U.S. Navy and strategic undersea programs. Management completed a new Navy manufacturing facility in Batavia during Q2 FY2026, representing a $17.6M expansion supported by a $13.5M customer grant. Automated welding machines were fully installed and commissioned, and a new X-ray inspection facility remained on track later in the fiscal year. These are not vanity projects. They are capacity and quality investments aimed squarely at long-cycle Navy work.
Space is smaller today, but it still matters strategically. FY2026 segment data shows $14.5M of space revenue. Management highlighted several milestones, including completion of liquid nitrogen testing capability in Arvada and construction of a new cryogenic test facility in Jupiter, Florida. The company said these investments expand in-house testing capability and support customers as programs move from development into higher-rate production. In plain English, Graham is trying to position itself upstream of future volume ramps rather than waiting for them to arrive.
Commercial exposure has become less visible in the reported segment mix, but it remains important through energy, process, aftermarket, and now FlackTek. In Q3 FY2026, management said energy and process sales increased $2.1M, or 13%, helped by aftermarket demand and momentum in new energy markets, particularly SMRs. At the same time, management also said it was seeing some slowing in large capital purchases due to lower oil prices, tariffs, and an uncertain macro environment. That is the commercial side of the story in one sentence: useful growth pockets, but less clean visibility than defense.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
The most interesting flagship product in the current Graham story is FlackTek’s MEGA platform. Management described MEGA as the world’s only production-scale bladeless dual asymmetric centrifugal mixer capable of processing multi-hundred-kilogram batches in a 55-gallon drum format. That is a mouthful, but the investment point is simple: it is differentiated equipment that can materially improve customer throughput.
According to management, MEGA can reduce mixing cycles from hours to minutes while maintaining precision, repeatability, and quality consistency at scale. Those are exactly the traits customers pay up for in defense, space, energy, and advanced industrial applications. When a machine cuts cycle time that dramatically, it stops being a line item and starts becoming a bottleneck remover. Markets tend to reward companies that own bottleneck removers.
FlackTek itself brings about $30M of annual revenue, more than 2,500 installed units globally, and a portfolio of proprietary intellectual property. Management also said the installed base drives recurring demand for consumables, accessories, and services. That recurring layer matters because Graham’s legacy business is more project-based. FlackTek adds a steadier revenue stream and potentially better lifetime economics.
The other notable product angle is Xdot’s patented foil bearing technology. Management said Xdot’s designs deliver superior performance while reducing development and production costs, and that the technology is already being leveraged with Barber-Nichols turbomachinery capabilities to win future opportunities. If MEGA is the flashy growth story, Xdot is the quieter engineering upgrade that can deepen Graham’s moat in high-speed rotating machinery.
Graham’s competitive advantage comes from a mix of technical specialization, qualification barriers, and customer entrenchment. The 10-K says the company has a leading position and in some cases a sole-source position in certain defense systems. That is about as clear a moat signal as an industrial filing gives. In defense and space, once a supplier is qualified into a critical platform, replacing it is expensive, slow, and risky.
The company is also broadening its technology stack. Management now frames Graham around three core technology platforms: vacuum and heat transfer, high-speed turbomachinery, and advanced materials processing through FlackTek. That matters because it lets the company solve more complex customer problems across multiple disciplines. It also creates more cross-sell potential across the same end markets.
Management’s own language is revealing here. It said FlackTek strengthens Graham’s ability to solve increasingly complex customer challenges that require integrated solutions across multiple disciplines, and that these capabilities span the value chain from formulation and upstream processing through downstream production and quality control. Translated from corporate dialect, Graham is trying to become harder to displace by owning more of the engineering stack around the customer’s process.
There is also a practical moat in manufacturing know-how. The company has invested in automated welding, cryogenic testing, Navy-focused production capacity, and an expanded engineering and service footprint in India. Those investments are not as glamorous as software, but in industrial markets they matter. Precision fabrication, testing capability, and field support are often where theoretical competitors discover that PowerPoint is not a factory.
Operationally, Graham looks much stronger than it did several years ago. Annual gross margin improved from 7.4% in FY2022 to 16.2% in FY2023, 21.9% in FY2024, and 25.2% in FY2025. Operating margin improved from -9.2% in FY2022 to 7.2% in FY2025. That is not random fluctuation. It points to a business that has rebuilt pricing, mix, and execution.
Quarterly data shows some noise but still a healthy pattern. Revenue was $55.5M in June 2025, $66.0M in September 2025, and $56.7M in December 2025 before rising to $67.1M in Q4 FY2026. Gross margin moved from 26.5% to 21.7% to 23.0% in those reported quarters, while management said Q3 FY2026 gross margin was 23.8% and the year-over-year decline reflected sales mix and a higher level of material receipts. For project-heavy manufacturers, that kind of quarter-to-quarter movement is normal. The broader trend is what matters, and the broader trend is up.
Tariffs have been a real but manageable headwind. Management estimated tariffs impacted the first nine months of FY2026 by about $1M and narrowed the full-year tariff impact to $1M to $1.5M. The 10-K also cited approximately $1M of tariff impact in fiscal 2026. That is not trivial for a company of this size, but it is also not thesis-breaking. Management credited sourcing discipline, in-country partnerships, and contractual protections for limiting the damage.
Supply-chain and operating investments continue. The Arvada, Colorado assembly and test facility renovation was completed and became fully operational. The company launched an aftermarket acceleration initiative using AI tools to improve responsiveness, pricing, and service penetration. It also expanded and consolidated engineering and service operations in India to improve cost efficiency and scalability. None of these moves alone changes the story, but together they show a company trying to convert backlog into a more repeatable operating machine.
Graham sits inside the broader industrial machinery and engineered systems market, but its real addressable market is narrower and better than that label implies. The company sells into mission-critical niches where performance, qualification, and reliability matter more than sticker price. That is why broad industrial TAM figures are useful only as background. Mordor Intelligence estimates the global industrial machinery market at $0.87T in 2026, rising to $1.31T by 2031, but Graham is not trying to win a commodity slice of that ocean.
The more relevant market framing comes from Graham’s own disclosed opportunity set. Company materials cited a Graham revenue opportunity of about $1.7B through 2056 based on strategic platform projections, including about $300M for Ford-class carriers, $800M for Virginia-class submarines, $500M for Columbia-class submarines, and $150M for torpedoes. That is not a total company TAM in the Silicon Valley sense, but it is a concrete, long-duration opportunity map tied to programs Graham already understands.
The commercial side also has attractive pockets. Management highlighted momentum in SMRs, cryogenics, and advanced materials processing. FlackTek expands Graham into applications across defense, space, energy, process, medical, personal care, and battery technology. The common thread is process-critical equipment where customers need precision and repeatability. That is a healthier place to play than low-spec industrial machinery, especially when labor scarcity and automation demand are pushing customers toward more advanced equipment.
Still, the market is not one-way traffic. Management explicitly said large capital purchases in energy and process were slowing due to lower oil prices, tariffs, and macro uncertainty. That means Graham’s commercial markets are offering selective growth rather than broad acceleration. For now, defense is carrying the weight, and that is both the opportunity and the concentration risk.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
Graham’s customers are not casual buyers. They are defense contractors, U.S. Navy-linked programs, space customers, energy and process operators, and industrial users with mission-critical applications. These buyers care about qualification, performance under demanding conditions, and long-term reliability. In many cases, the cost of failure is far larger than the cost of the equipment.
The defense customer profile is especially attractive from a visibility standpoint. The 10-K notes that defense orders can take 3 to 7 years from award to shipment. That long cycle can make quarterly revenue lumpy, but it also creates sticky relationships and a backlog base that is hard for competitors to dislodge. Management said approximately 35% to 40% of backlog is expected to convert to revenue over the next 12 months, with another 25% to 30% converting within 1 to 2 years.
FlackTek broadens the customer profile further. Management said about 60% of FlackTek sales are into energy and process, 15% to defense, and 10% to space. It also emphasized FlackTek’s installed base and recurring demand for consumables, accessories, and services. That gives Graham a customer set with more recurring behavior than the legacy engineered-to-order model alone.
Geographically, international sales were 15% of total sales in fiscal 2026, according to the 10-K. That means Graham remains predominantly domestic, which fits management’s stated M&A criteria and reduces some foreign-exchange and geopolitical complexity. It does not eliminate those risks, but it keeps them in proportion.
A formal peer screen was not available in the provided data, so the competitive picture has to be built from company disclosures and business structure rather than a clean valuation table. Even so, the broad outline is clear. Graham competes in specialized industrial and defense-adjacent niches where engineering capability, qualification history, and manufacturing execution matter more than scale alone.
The strongest competitive fact is from the company’s own 10-K: Graham has a leading position, and in some instances a sole-source position, for certain defense systems and equipment. That is a very different competitive setup from a standard machinery company fighting on price. Sole-source or near-sole-source positions can support pricing power, long program duration, and customer stickiness.
FlackTek adds another layer of differentiation. Management said the biggest competitor for FlackTek in some applications is “a bucket in a stick,” meaning manual mixing. That sounds almost too simple, but it captures the point. When the incumbent alternative is manual or low-tech, a differentiated automated platform can create its own category. That does not mean competition disappears. It means the fight shifts from price to adoption and qualification.
The main competitive risk is not a direct rival suddenly building a better vacuum system. It is execution. In niche industrial markets, customers often stay with the supplier that delivers on time, meets spec, and avoids drama. Management’s comments about additional scope on existing defense programs because Graham is meeting customer requirements in time, speed, and quality are therefore important. In this business, reliability is a sales strategy.
Graham’s macro exposure is unusual because the company has one foot in industrial cyclicality and the other in defense spending. On the industrial side, lower oil prices, tariffs, and uncertain macro conditions have already slowed some large energy and process capital purchases. On the defense side, demand tied to strategic undersea programs remains healthy, according to management, and backlog remains heavily defense-weighted.
The 10-K lays out the geopolitical risk clearly. It cites the Russia-Ukraine war, Israel-Hamas and Iran conflicts, changes in Venezuela, and recent trade-related actions as factors that can raise transportation, energy, and raw-material costs, disrupt supply chains, and increase tariffs and inflation. Those are not abstract risks for Graham. The company quantified tariff impact at about $1M in fiscal 2026.
Interest-rate risk is present but manageable. The company uses a revolving credit facility with variable-rate debt to fund strategic growth, including acquisitions. As of March 31, 2026, the 10-K said Graham had $13M of variable-rate debt outstanding and no interest-rate derivatives. Later, management said that after the FlackTek acquisition only $20M of debt was outstanding under the expanded $80M revolver. For a company with $22.3M of cash at Q3 FY2026 and positive operating cash flow, that debt load is meaningful but not alarming.
The bigger macro variable is U.S. defense funding. Graham’s defense concentration has become a strength in the current environment, but it also means appropriations delays, program changes, or procurement shifts would hit harder than they did when the company had a larger commercial mix. That is the tradeoff. Defense backlog brings visibility, but it also ties the story to Washington’s budget plumbing, which is not always elegant.
An A- balance sheet and management’s $17.6M Navy facility expansion, backed by a $13.5M customer grant, give Graham flexibility to keep investing without stretching the capital structure.
Unlock the full analysis
Subscribers get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →FY2026 revenue rose 17% to $245.3M and GAAP EPS reached $1.12, while gross margin held at 25.2% in FY2025 and management guided 24.5% to 25.5% for FY2027.
Unlock the full analysis
Subscribers get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Management is guiding FY2027 adjusted EBITDA to $35M-$40M, with backlog at a record $532.6M and book-to-bill at 1.5x supporting continued growth visibility.
Unlock the full analysis
Subscribers get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →At 79.3x trailing earnings, 54.9x forward earnings, and 3.05x PEG, Graham’s valuation leaves little room for execution missteps even with strong defense demand.
Unlock the full analysis
Subscribers get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Analyst targets are mixed, with a $100.25 consensus split between 1 Buy and 1 Hold, while a separate six-analyst target set sits lower at $81.67 versus the June 5, 2026 share price of $106.81.
Unlock the full analysis
Subscribers get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Graham Corporation is a much better company today than it was during its uneven FY2021 to FY2023 stretch. Revenue has scaled, margins have improved, backlog has surged, and management has added new technology platforms that can deepen the moat and diversify the model. The defense franchise is the anchor, and right now it is a strong one.
There is a lot to like in the facts. FY2026 revenue reached $245.3M. Backlog hit a record $532.6M. Orders were $359M. Book-to-bill was 1.5x. FY2027 guidance calls for $285M to $295M of revenue and $35M to $40M of adjusted EBITDA. Balance-sheet flexibility remains intact even after FlackTek. These are the numbers of a company with momentum, not a company hoping for one.
But investing is not just about admiring the business. It is about the price paid for it. With a fair value estimate of $92 and the stock recently around $106.81, the setup looks respectable rather than compelling. For existing shareholders, Graham still merits patience. For new money, discipline matters. This is a name to own on the right price, not to chase simply because the story has improved.
Graham Corporation (GHM) fell after a deeper look at earnings showed an EPS miss despite a revenue beat. The analysis weighs margin pressure, defense and space momentum, record backlog, and fiscal 2027 guidance against a stock that had already run up into the print.
Graham Corporation (GHM) slumps 16.0% after reporting earnings misses, as investors react to weaker-than-expected results and pressure on the stock.
Veraxa Biotech AG Ordinary Shares (NASDAQ: VRXA) is expected to list on 2026-06-10, but the price range has not been disclosed. This is a SPAC business combination rather than a traditional IPO, with the story centered on a pre-commercial oncology pipeline. Bull case: a differentiated antibody-therapy platform; bear case: no product revenue yet and heavy financing needs.